| Application no. and date | 10160846.1 (espacenet) (Federated) (European Patent Register), 20060616 | | Patent/reg. no. and date | DK/EP 2204174, 20120516 | | Publication date | 20100707 | | Priority no. and date | FR 0506182, 20050617 | | EP pub. no. and date |
EP 2204174 20100707 | | Effective date | | | Applicant/owner | Galderma S.A., Zugerstrasse 8
6330 Cham, CH | | Applicant ref. no. | LOR05207 | | Inventor | Mallard, Claire,
Domaine La Jouvencelle 1122 Chemins du Château
06250, MOUGINS, FR,
Brzokewicz, Alain,
Les Hauts des Fauvettes 140 Route d'Antibes
06560, VALBONNE, FR | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/4164 (2006.01) , A61K 47/10 (2006.01) , A61K 47/22 (2006.01) , A61K 9/08 (2006.01) , A61P 17/00 (2006.01) | | Title | Fremgangsmåde til opløseliggørelsen af metronidazol ved hjælp af niacinamid og to glycoler, og den således opnåede opløsning | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
